Researches from the University of Adelaide and the University of Colorado identified an immune receptor in the brain that is activated by opioids and triggers inflammation. They then demonstrated how the immune receptor can be blocked.
“Because morphine is considered to be such an important drug in the management of moderate to severe pain in patients right around the world, we believe these results will have far-reaching benefits,” said study co-author Mark Hutchinson, MD.
Related Articles on Pain Management:
10 Tips for Engaging Pain Management Patients Through YouTube
FDA Researcher Calls for Abuse-Resistant Opioids, Nonopioid Pain Therapy
Funding Surges for Deep Tissue Pain Therapy Device
